NASDAQ · Shell Companies

DA32 Life Science Tech Acquisition Corp. (DALS) Stock

$10.30 -0.19% NASDAQ: DALS Financial Services

Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities.

Valuation

MetricValue
Price$10.30
Market Cap$264.19M
P/E Ratio85.83
P/B Ratio—
P/S Ratio—
EPS (TTM)$0.12
52-Week High$11.22
52-Week Low$9.68
Dividend Yield—

Financials & Margins

MetricValue
ROE-20.00%
ROA0.49%
ROCE-0.99%
Gross Margin—
Operating Margin—
Net Margin—
Debt/Equity0.00
Current Ratio1.00

Annual Financials (USD)

Metric2022
Revenue—
Operating Profit$-2.0M
Net Profit$1.0M
EPS$0.12
Op Margin—

Balance Sheet (USD)

Metric202120212022
Total Assets—$202.0M$204.0M
Total Liabilities—$6.0M$7.0M
Cash$0$0$0
Borrowings———

Cash Flow (USD)

Metric2022
Operating Cash Flow$-1.0M
Investing Cash Flow$0
Financing Cash Flow$0
Net Cash Flow$-1.0M
Free Cash Flow$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-0.38%
Quick Ratio1.00
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CRZNCorazon Capital V838 Monoceros Corp $10.22 — -190.06 $260.48M 0.00%
IGNYIgnyte Acquisition Corp. $13.05 +14.57% -21.39 $261.76M 0.00%
KITTNauticus Robotics, Inc. $1.48 -0.67% -0.01 $1.84M 0.00%
PANAPanacea Acquisition Corp. II $10.24 -0.10% — $241.10M 0.00%
PRPCCC Neuberger Principal Holdings III $10.95 -0.09% 6.33 $214.62M 0.00%

About DA32 Life Science Tech Acquisition Corp.

Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promising candidates for these combinations within the biotechnology and life science infrastructure sectors. Established in 2021, the company is based in New York, New York.

DA32 Life Science Tech Acquisition Corp. is headquartered in US.

DA32 Life Science Tech Acquisition Corp. (DALS) stock trades at $10.30 with a market capitalization of $264.19M. The stock is valued at a price-to-earnings (P/E) ratio of 85.83. Over the past 52 weeks the stock has ranged between $9.68 and $11.22, and currently trades 8.2% below its 52-week high.

On profitability, DA32 Life Science Tech Acquisition Corp. generates a return on equity (ROE) of -20.00% (negative, reflecting a net loss), return on capital employed of -0.99%.

Related Financial Services Stocks

BRK.A Berkshire Hathaway Inc. $733370.00 +0.00% BRK.B Berkshire Hathaway Inc. New $482.70 +0.00% JPM JP Morgan Chase & Co. $332.99 +0.47% V Visa Inc. $385.45 +2.76% MA Mastercard Incorporated $589.14 +2.66% BAC Bank of America Corporation $54.32 +1.32% HSBC HSBC Holdings, plc $92.98 +0.40% MS Morgan Stanley $190.02 +1.38% RY Royal Bank Of Canada $191.91 +0.71% GS Goldman Sachs Group, Inc. (The) $895.32 +1.44% WFC Wells Fargo & Company $83.55 +1.85% MUFG Mitsubishi UFJ Financial Group, Inc. $22.38 -0.44%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)Exxon Mobil (XOM)

Related stock screens

High ROE Financial Services StocksLow P/E Financial Services StocksHigh Net Margin Financial Services StocksDividend Financial Services StocksLow Debt Financial Services StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.